Universal Beteiligungs und Servicegesellschaft mbH Has $10.94 Million Stock Holdings in Tenet Healthcare Corporation $THC

Universal Beteiligungs und Servicegesellschaft mbH increased its position in shares of Tenet Healthcare Corporation (NYSE:THC) by 12.9% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 62,153 shares of the company’s stock after buying an additional 7,084 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Tenet Healthcare were worth $10,939,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of THC. Chung Wu Investment Group LLC bought a new stake in Tenet Healthcare during the 2nd quarter valued at $35,000. SVB Wealth LLC bought a new stake in shares of Tenet Healthcare during the first quarter worth about $30,000. N.E.W. Advisory Services LLC acquired a new stake in shares of Tenet Healthcare in the 1st quarter worth about $31,000. Brooklyn Investment Group lifted its holdings in shares of Tenet Healthcare by 908.7% in the first quarter. Brooklyn Investment Group now owns 232 shares of the company’s stock valued at $31,000 after purchasing an additional 209 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd boosted its holdings in Tenet Healthcare by 2,227.3% during the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 256 shares of the company’s stock worth $45,000 after acquiring an additional 245 shares during the last quarter. 95.44% of the stock is owned by institutional investors and hedge funds.

Tenet Healthcare Price Performance

NYSE:THC opened at $193.68 on Thursday. The firm has a market capitalization of $17.02 billion, a price-to-earnings ratio of 13.27, a P/E/G ratio of 0.89 and a beta of 1.53. The company has a debt-to-equity ratio of 2.27, a quick ratio of 1.63 and a current ratio of 1.71. The stock has a fifty day moving average of $198.88 and a 200 day moving average of $179.61. Tenet Healthcare Corporation has a 52-week low of $109.82 and a 52-week high of $217.43.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Tuesday, October 28th. The company reported $3.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.33 by $0.37. The firm had revenue of $5.29 billion during the quarter, compared to the consensus estimate of $5.26 billion. Tenet Healthcare had a return on equity of 25.11% and a net margin of 6.49%.The company’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter last year, the company posted $2.93 EPS. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. On average, research analysts expect that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

Analysts Set New Price Targets

THC has been the topic of a number of research analyst reports. JPMorgan Chase & Co. boosted their target price on Tenet Healthcare from $200.00 to $230.00 and gave the stock an “overweight” rating in a research note on Thursday, November 13th. Wolfe Research downgraded shares of Tenet Healthcare from an “outperform” rating to a “peer perform” rating in a research note on Monday, July 28th. Robert W. Baird dropped their price target on shares of Tenet Healthcare from $195.00 to $167.00 and set a “neutral” rating on the stock in a research note on Friday, July 25th. Wall Street Zen raised shares of Tenet Healthcare from a “hold” rating to a “strong-buy” rating in a report on Saturday, July 26th. Finally, Wells Fargo & Company raised their price target on Tenet Healthcare from $238.00 to $252.00 and gave the stock an “overweight” rating in a report on Thursday, November 13th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $229.00.

Insider Activity at Tenet Healthcare

In other news, Director Richard W. Fisher sold 2,500 shares of Tenet Healthcare stock in a transaction on Wednesday, October 29th. The shares were sold at an average price of $208.43, for a total transaction of $521,075.00. Following the completion of the sale, the director directly owned 8,792 shares of the company’s stock, valued at approximately $1,832,516.56. The trade was a 22.14% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Saumya Sutaria sold 78,762 shares of the firm’s stock in a transaction dated Wednesday, September 10th. The shares were sold at an average price of $190.78, for a total value of $15,026,214.36. Following the sale, the chief executive officer owned 368,683 shares in the company, valued at $70,337,342.74. The trade was a 17.60% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 122,092 shares of company stock worth $23,844,663. Corporate insiders own 0.81% of the company’s stock.

Tenet Healthcare Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.